The cell and gene therapy sector has never lacked attention, but all too often, the narrative swings from one extreme to ...

TRX Gold Corporation (TSX: TRX) (NYSE American: TRX) (the “Company” or “TRX Gold”) reported its results for the first quarter ...

A new white paper from BioDlink, From Complexity to Consistency: How CDMOs Can Unlock One-Step, High-Yield and Homogeneous ...

Precigen, Inc. ( PGEN) 44th Annual J.P. Morgan Healthcare Conference January 15, 2026 10:30 AM EST ...

TRX Gold Corporation (TSX: TRX) (NYSE American: TRX) (the "Company" or "TRX Gold") reported its results for the first quarter ...

The World Economic Forum welcomes 23 new industrial sites to its Global Lighthouse Network, demonstrating how advanced technologies can improve ...

New FDA communication introduces a more flexible, risk‑based chemistry, manufacturing, and controls (CMC) framework for cell and gene therapies, including phased data submission to support earlier ...

Scientists have transformed enigmatic cell structures, called vaults, into storage units for messenger-RNA molecules made in ...

Cell therapy manufacturing is patient-specific and time-sensitive, making regional production capacity increasingly important.

STAAR Surgical Company ("STAAR" or the "Company") , the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICLtm) for vision correction, and Broadwood Partners, L.P.